ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Big Week for Autos, Pharma and Banks

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Over 1,200 companies report this week. Today kicks things off with Roche posting results. The Swiss pharma giant carries a $379bn market cap. Rentokil Initial and Sasol also report today.

Thursday brings the most watched auto prints. Volvo Car reports alongside Renault. ORTEX alt data offers a mixed read for both. Austrian car registrations are running 6% above last year, pointing modestly higher for Renault revenue. Dutch registrations are down 19%, a counterweight. For Volvo Car, Finnish registrations are tracking 9% below the same quarter last year. India registrations point the other way, up 9%.

Also Thursday, Maruti Suzuki reports in India. India registration data, which leads Maruti revenue by 58 days, is running 31% above last year.

Mercedes-Benz and Volkswagen follow later in the week. Dutch registrations, a strong leading indicator for Mercedes revenue, are down 6% year on year. VW faces Austrian registrations down 6%.

No IPOs are scheduled in the next seven days.

On the index front, PBF Energy sits on the knife-edge between the Russell 1000 and Russell 2000. The 30 October rank date decides. A swing either way could force between $411m and $1.1bn of tracker flows.

Taiwan export orders hit a record $114.2bn in September, up 62% year on year. That context matters for any tech supplier reporting this week.

Stocks in this article

How this article was generated

Generated
22 Oct 2026, 04:30
Prompt version
v1.0
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.